The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Phenotypic Expression of Disease in Families That Have Mutations in the 5′ Region of the Adenomatous Polyposis Coli Gene

Francis M. Giardiello, MD; Jill D. Brensinger, MS; Michael C. Luce, PhD; Gloria M. Petersen, PhD; Matthew C. Cayouette, BS; Anne J. Krush, MS; Judith A. Bacon, BS; Susan V. Booker, BA; Jose A. Bufill, MD; and Stanley R. Hamilton, MD
[+] Article, Author, and Disclosure Information

For author affiliations and current author addresses, see end of text. For definitions of terms used in this article, see glossary at end of text. Acknowledgments: The authors thank Drs. Mary C. Corretti, Larry Blessing, Dana Fouchi, Neil Rakov, and Michael Phillips and Ms. Linda Welch for technical support. Grant Support: In part by the Clayton Fund and National Institutes of Health grants CA 62924, CA 53801, and CA 63721. Requests for Reprints: Francis M. Giardiello, MD, Blalock 935, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287. Current Author Addresses: Dr. Giardiello: Blalock 935, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287.

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 1997;126(7):514-519. doi:10.7326/0003-4819-126-7-199704010-00003
Text Size: A A A

Background: Germline mutation in a gene on chromosome 5 (the adenomatous polyposis coli gene) causes familial adenomatous polyposis of the colorectum. Phenotypic manifestations of this condition vary, but the exact relation of the phenotype to the mutation site along the gene has not been fully described.

Objective: To determine how the location of mutations along a gene that is associated with multiple colorectal polyps (the adenomatous polyposis coli gene) is related to the phenotypic expression of the syndrome in families.

Design: Prospective cohort study.

Setting: Polyposis registry.

Patients: 20 patients from 7 families that had mutations in the adenomatous polyposis coli gene that were located toward the 5′ end of codon 158 (proximal 5′ families), were compared with 52 patients from 7 families that had mutations downstream from codon 158, in codons 179 to 625 (distal 5′ families).

Measurements: Sex, age at diagnosis of familial adenomatous polyposis, number of polyps at first examination of the colon, distribution of polyps, age at diagnosis of colorectal cancer, and location of colorectal cancer.

Results: Mutations that were proximal to codon 158 were found in 7 of 112 families (6%). At the first examination of the colon, 8 of 17 (47%) patients in proximal 5′ families and 9 of 48 (19%) patients of similar ages in distal 5′ families were found to have fewer than 100 adenomas (P = 0.029). The distribution of polyps was frequently right-sided in patients in proximal 5′ families (P = 0.001). The cumulative probability of survival without colorectal cancer was greater for patients in proximal 5′ families (P = 0.041).

Conclusions: Families with adenomatous polyposis that have proximal 5′ mutations of the adenomatous polyposis coli gene are more likely to have a heterogeneous phenotype with delayed development of colonic polyposis and colorectal cancer than are families with distal 5′ mutations of the gene. Management should include genotyping of patients who are at risk, colonoscopic surveillance of genotypically positive persons, and prophylactic colectomy if several adenomas are found.


Grahic Jump Location
Figure 1.
The adenomatous polyposis coli gene.

Codon location of mutations in proximal 5′ and distal 5′ families is shown.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Life table analysis of onset of colorectal cancer in proximal 5′ and distal 5′ families.P

Onset was delayed in patients in the proximal 5′ families ( = 0.041 by log-rank test). The top row of numbers above the x-axis shows how many patients were being observed in the proximal 5′ families, and the bottom row shows the corresponding numbers for the distal 5′ families.

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Journal Club
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.